Full Text Hide / show
Introduction
As a result of the blood stage infection, malaria damages the infected host. The host’s reactions to the infection and the increased lysis of both infected and uninfected erythrocytes cause illness [1]. When mature stages of the parasite infect erythrocytes, they attach themselves to the cellular endothelium by interacting with human receptors like Endothelial Protein C Receptor (EPCR), Cluster of Differentiation 36 (CD36), and Intracellular Adhesion Molecule-1 (ICAM-1). They can also attach themselves to non-infected erythrocytes to form “rosettes” or to platelets to form agglutinates. An antibody “footprint” left by malaria infection is persistent beyond the illness itself [2]. Strong pro-inflammatory reactions including pyrogenic cytokines, such as interleukin (IL)-1β and tumour necrosis factor alpha (TNF-α), are what produce paroxysmal fever in cases of Plasmodium falciparum infection.
While inflammatory reactions, such as interferon gamma (IFN-γ), IL-12, IL-1β, IL-2, and TNF-α all have vital functions in aiding in the removal of parasites; elevated levels of these cytokines in the blood have been linked to malaria immunopathology [3]. Malaria and miRNAs have a dynamic relationship that is yet poorly understood. As a result, certain genes are identified by the authors as potential biomarkers for malaria infection, including CD36, IFN-γ, Toll-like Receptor 4 (TLR4), and Proline Rich 15 (PRR15). These genes are expressed as miRNAs. miRNA biogenesis Beginning with pri-miRNAs, the synthesis of miRNA is processed by the cellular nucleases Drosha and Dicer to produce mature miRNAs. When miRNAs bind to complementary sequences in the 3’ Untranslated Region (UTR) of their target mRNAs in animals, they primarily inhibit the expression of those genes by either via mRNA transcript destruction or translational suppression; in animals, two processing steps result in the creation of mature miRNA.
PrimormiRNA, the immature miRNA transcripts, are processed into ~70-nucleotide precursors (premiRNA) in the first event. This precursor is then cleaved to produce ~21–25 nucleotide mature miRNAs in the second event that follows. Following synthesis, the transcripts of miRNAs are then processed. MiRNAs in circulation The invasion of microorganisms (bacteria, viruses, and parasites) in humans is linked to immune system function and gene expression, which is correlated with the severity of disease and the evaluation of medication efficacy [9]. The presence of a pathogenic agent in systemic infections frequently causes a notable alteration in the profile of circulating miRNAs, which makes it easier to employ these molecules as biomarkers of the onset and course of disease.
In some circumstances, such viral infections, these modifications in the circulating It has been shown that miRNAs are linked to the targeted cell in both acute and chronic hepatitis C virus infections. In the immune response that follows a malaria infection, parasitic flatworms like Schistosoma japonicum cause a differential expression of circulating miRNAs in the liver and other organs. Numerous miRNA are known to regulate gene expression, susceptibility to infection, stress responses, and metabolism in addition to cell growth and proliferation. Biomarkers and microRNAs in malaria It has been demonstrated that host-pathogen interactions affect the content of miRNAs in the host in the cases of bacteria, viruses, and apicomplexan parasites, such as malaria parasites.
Crucially, Plasmodium falciparum’s cyto-adhesion to host receptors can initiate intracellular signals in target cells and perhaps impact a variety of physiological responses controlled by miRNAs. such is the production of adhesion molecules, vascular inflammation, and bone marrow cell parenchymal injury. Previous research indicates that Plasmodium falciparum may manipulate host miRNAs despite its inability to produce miRNAs. This suggests that these small molecules may be useful in elucidating the molecular mechanisms underlying severe malaria and sickle cell resistance, as well as in determining the extent of vital organ dysfunction linked to parasite sequestration—which is thought to be a critical pathogenic event in Plasmodium falciparum. As a result, miRNAs released from host tissues injured by Plasmodium falciparum sequestration, such as the liver, spleen, brain, or lung, may one day be used as a diagnostic for a severe form of malaria [14].
Infected Red Blood Cells (RBCs) and/or parasite-derived metabolites stimulate the Toll-like receptors (TLRs), which are well studied in relation to malaria. This stimulation results in the release of pro-inflammatory cytokines like IFN-γ, IL-12, and TNF-α, as well as nitric oxide, which are crucial for managing the acute bloodstage infection. Severe malaria, however, might arise from an overactive or dysregulated inflammatory response [15]. Variations in miRNA Controlling the amount of mRNA and the expression of proteins depends on miRNA binding to mRNA. Single-nucleotide polymorphisms, which may exist in the miRNA target site, have the ability to influence this interaction by eradicating preexisting binding sites or generating new, illegitimate binding sites. Consequently, variations in miRNA polymorphisms might impact gene and protein expression differently and represent an additional kind of genetic diversity that may impact a person’s susceptibility to specific illnesses [7].
TLR4 and TLR9 polymorphisms have been linked to higher parasitemia in cases of Plasmodium falciparum infection or mixed infections, as well as susceptibility to malaria [16]. The transcription process may cause these genes to express. Supplies and Procedures An overview of this project Figure 1 shows the procedure for this project. First, the chosen malarial genes were located in the relevant sources. Employing the genes that have been chosen are Homo sapiens. Second, the list of miRNAs connected to linked genes was obtained by entering the gene symbol into the target scan software and submitting it. The NCBI database (www.ncbi.nim.nih.gov) provided the human 3’UTR sequences for the genes. Forecasting miRNAs Three distinct algorithms—miRanda, RegRNA, and Target Scan—which are the most popular in the updated version—were employed to study the prediction of miRNAs.
Nevertheless, in our work, we just employ Target Scan and miRanda to forecast the correlation between the chosen genes and particular miRNAs. RegRNA, on the other hand, is unable to forecast since the associated genes have an excess of nucleotides. The process of computationally identifying the malaria-related miRNAs . Scan for targets Target Scan predicts miRNA target locations shared by orthologous vertebrate 3UTRs [17–19]. Mammals’ predictions are ordered according to the expected effectiveness of targeting, which is determined by adding the site’s content scores to their probability.Target Scan is thus further described in the section on whole genome alignments. On the other hand, miRanda favours the quantity of Low mirSVR scores, which encompass the entire family of miRNAs.
The process of computationally identifying the malaria-related miRNAs MiRanda The mirSVR score was found using the miRanda programme. Genes were entered into the “Target mRNA” column. Predictions were then initiated by selecting “go” and “alignment.” The resulting prediction included a mirSVR score that encompassed the entire family of miRNAs. Figure 2 depicts the process of computationally identifying the miRNAs implicated in malaria. Selection criterion for miRNAs The genes and miRNAs that are associated throughout the prediction processes provide the basis for the miRNA selection criteria. A high negative free energy indicated a higher likelihood of miRNA-mRNA duplex hybridization. A high negative mirSVR score indicated a higher likelihood of target inhibition.
A high negative content + score and a high probability of conserved target indicated a good candidate miRNA for target gene inhibition. These were the selection criteria that were applied. Outcomes Using bioinformatics methods, we detailed the prediction of CD36, IFN-γ, TNF-α, TLR4, and PRR15 associated with particular miRNAs. The genes’ forecasting was defined as follows: Target scan-based candidate gene prediction The stages involved in predicting candidate genes (such as CD36, IFN-γ, TLR4, and PRR15) are delineated in the materials and methods section. These steps serve to determine the correlation between the genes and certain miRNAs.Candidate gene prediction with miRanda Determine the relationship between target miRNAs and candidate genes (PRR15, TLR4, IFN-γ, and CD36).
We employed the miRanda programme to forecast the presence of a given miRNA. Production of microRNA candidates Malaria is an inflammatory disease that starts when innate immune cells, such as monocytes, dendritic cells, and macrophages, recognise parasite toxins like glycophosphatidyl inositol (GPI). This recognition triggers an intracellular signal transduction pathway that leads to the production of proinflammatory cytokines like interleukin-12 (IL-12), tumour necrosis factor-alpha (TNF-α), and interferon gamma (IFN-γ). Toll-like receptor 4, a major pathogen recognition receptor (PRR) expressed on the membrane surface of innate immune cells, is genetically encoded by the TLR4 gene. Since there is minimal expression of CD36, its function in cerebral malaria is unknown. on the endothelium cells of the cerebral microvasculature.
Cerebral endothelial cells produce ICAM-1 and other adhesion receptors,whichmaybeup-regulatedbyinflammatorycytokines such tumour necrosis factor (TNF)-α. High concentrations of pro-inflammatory cytokines, like TNF-α, have been linked to severe malaria and a dismal outlook. Hence, the chosen genes (PRR15, TLR4, IFN-γ, and CD36) become potential biomarkers for miR-146 and miR-155 in the malaria degradation pathway, which begins with gene transcription in the nucleus from primiRNA to pre-miRNA after Dorsha cuts it, and is exported into the cytoplasm from pre-miRNA to duplex and mature miRNA after dicer cuts it.
Conclusion
An infection with malaria boosts the host’s immune system. As a result, the genes produced could be used as potential genes for prediction utilising bioinformatics techniques. Using Target Scan, the CD36 was effectively linked to certain miRNAs during the prediction process; however, miRanda did not yield the same results. Moreover, miRanda can predict IFN-γ, whereas Target Scan is useless in doing so. Furthermore, TLR4 was able to foresee with miR-146 alone utilising both bioinformatics programmes. Furthermore, PRR15 was the only candidate gene that could be identified using two target miRNAs, such as miR- 146 and miR-155, in bioinformatics techniques. As a result, the candidate miRNAs (miR-146 and miR-155) that were linked to the possible genes (CD36, PRR15, IFN-γ, and TLR4) became biomarkers for malaria infection.
In conclusion, this work used bioinformatics techniques with specific miRNAs to predict the host microRNA that associated to severe and cerebral malaria infection as a possible biomarker from selected gene CD36, TLR4, IFN-γ, and PRR15.
References
- White NJ. Malaria parasite clearance. Malar J. 2017; 16(1):88.
- Folegatti PM, Siqueira AM, Monteiro WM, et al. A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection. 2017; 16(1):107.
- Ademolue TW, Aniweh Y, Kusi KA, et al. Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity. 2017; 16(1):145.
- Rangel, G., et al. Candidate microRNAs as Biomarkers in Malaria Infection: A Systematic Review. Current Molecular Medicine 2019; 20(1): 36-43.
- Correia CN, Nalpas NC, McLoughlin KE, et al. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol. 2017; 8:118.
- De Lacorte Singulani J, De Fátima Da Silva J, Gullo FP, et al. Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis. Biomedical Reports. 2017; 6(3):353-357.
- George GP, Mittal RD. MicroRNAs: Potential biomarkers in cancer. Indian J Clin Biochem. 2010; 25(1):4-14.
- Khoury S, Tran N. Circulating microRNAs: potential biomarkers for common malignancies. Biomark Med. 2015; 9(2):131-151.
- Rangel G. Circulating exosomal microRNAs as prognostic biomarkers in Cholangicarcinoma: A systematic review. Nano med Nano Sci Tech. 2021; 1: 1-7
- Cohen A, Combes V, Grau GE. MicroRNAs and malaria-A dynamic interaction still incompletely understood. J Neuroinfect Dis. 2015; 6(1).
- Ohashi J, Naka I, Hananantachai H, et al. Association of PECAM1/CD31 polymorphisms with cerebral malaria. Int J Mol Epidemiol Genet. 2016; 7(2):87-94.
- Preskill C, Weidhaas JB. SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers. Critical reviews in oncogenesis. 2013; 18(4):327-40.
- Chacon-Cortes D, Smith RA, Haupt LM, et al. Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility. BMC Med Genet. 2015; 16:107.
- Rubio M, Bassat Q, Estivill X, et al. Tying malaria and microRNAs: from the biology to future diagnostic perspectives. Malaria J. 2016;15:167.
- Dhangadamajhi G, Kar A, Rout R, et al. A meta-analysis of TLR4 and TLR9 SNPs implicated in severe malaria. Rev Soc Bras Med Trop. 2017; 50(2):153-60.
- Costa AG, Ramasawmy R, Malheiro A, et al. Implications of SNPs on toll-like receptor genes in malaria: What do we know? Rev Soc Bras Med Trop. 2017; 50(2):151-152.
- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15- 20.
- Molineaux L. The epidemiology of human malaria as an explanation of its distribution, including some implications for its control. Malaria. 1990: 913-98.
- Rawat M, Bhosale MA, Karmodiya K. Plasmodium falciparum epigenome: A distinct dynamic epigenetic regulation of gene expression. Genom Data. 2016; 7:79- 81.
This is a text version generated from the article. For the formatted version of record (with original tables & figures), download the PDF →